Low Voltage Cranial Electrical Stimulation

ENHANCING BRAIN NEUROMODULATION EFFECTS:

SYSTEMIC RELAXATION

BALANCING ADRENAL STRESS AND STEROID HORMONES

BENEFICIAL EFFECTS ON DEPRESSION, MOOD, ANXIETY AND INSOMNIA

CENTRAL PAIN REGULATION

REDUCED MUSCLE SPASTICITY

BETA BRAINWAVE AUGMENTATION FOR INCREASED ALERTNESS

TREATMENT OF SUBSTANCE ADDICTION


  • The LVtC Stimulator is a technological advance and development on the Modulated Electric Energy Stimulators and their derivatives, patented in the USA by Dr. Saul Liss, which have been used 1000s of times by physicians in the USA and worldwide. Patents of Dr. Saul Liss>


  • From our independent, biomedical electronics engineering design and stimulation waveform technological advances, compared to the earlier Liss devices (designed 1980-1990), the LVtC Stimulator delivers a higher precision stimulation waveform.

    The LVtC Stimulator is the first waveform-generating cranial electrical stimulation (CES) device that achieves comparative or greater, known CES therapeutic effects, with extremely low applied stimulation electrical voltages (1000× lower) in the milli-volt range.



HOW IT WORKS: NEUROTRANSMITTERS

  • ‘Neurotransmitters’ are a class of the body’s chemical messengers. They are the molecules used by the nervous system to transmit messages between its nerve cells (‘neurons’), and from neurons to muscle cells. Neurotransmitters influence neurons in excitatory, inhibitory and modulatory ways.


  • Neurotransmitters control and influence many major body functions including breathing, heartbeat, movement, emotional response, concentration, mood, feelings of pleasure and satisfaction, and pain signal transmission and perception.



Neuron Neurotransmitter Junction

  • The LVtC Stimulator influences nerve activity by delivering electrical energy, in the form of specific frequencies, to the brain. The electrical energy penetrates into the brain via a specially, amplitude ‘modulated’ waveform, which acts as a ‘carrier’ of the actual stimulation frequencies. To achieve this carrier function, the modulated waveform is specially designed to utilize to advantage the composite electrical properties (‘impedance’) of the bones of the skull, to transmit the stimulating electrical energy.

    The published CES and Liss Modulated Electric Energy Stimulator research shows strong beneficial alteration of the levels of neurotransmitters: serotonin—related to mood, sexual function, appetite, sleep, memory, learning and some social behavior, melatonin—related to sleep-wake cycles, beta-Endorphin & GABA—related to transmission and sensation of pain, and on cortisol and DHEA—adrenal stress and steroid hormones, measured in the cerebral spinal fluid in the brain and spinal cord, and in the bloodstream.


HOW IT WORKS: BRAINWAVE AUGMENTATION

  • Also designed for brainwave augmentation, the LVtC Stimulator delivers stimulation frequencies that are in the ‘Beta’ brainwave band.



Frequency Bands of Brain Waves

  • Beta brainwaves are associated with the normal, waking state of consciousness of focused activity, decision-making and general alertness.



SUPPORTING EVIDENCE & HEALTH REGULATIONS

  • Modulated electric energy stimulation—under the category of cranial electrical stimulation (CES)—is backed in the USA by 30+ peer-reviewed published studies, around 20 patents, and by the USA Food and Drug Administration (FDA) and Health Canada marketing clearance for the treatment of anxiety, depression, and insomnia disorders.

    Applications are drug free and no negative effects or major contraindications have been reported from the use of amplitude modulated frequency CES.



LVtCS DEVELOPMENT

  • Neurosurgeon, C. Norman Shealy used the first implantable neuromodulation electrotherapy device for the treatment of chronic pain in 1967. Later on, he found that the same effects could be achieved via non-invasive electrical stimulation.

  • The original Modulated Electric Energy Stimulator technology was gradually developed and patented beginning in the 1980s by scientist and medical engineer, Dr Saul Liss (-2006) together with Shealy.

  • "Modulated Electric Energy Stimulators are devices which . . . have a beneficial clinical effect on the human in reducing pain, and symptoms of depression, anxiety, and insomnia . . . to reduce spasticity, enhance alertness and increase attention span in the normal and increase the cognitive performance of neuronally deficient children." [Liss 1999]

  • The technology was developed from "analyzing the physics characteristics of the body and match[ing] the dynamic electrical 'impedance' [part of which is electrical resistance] of the body with a stimulation pattern which the body could then convert into an internal signal that it could use constructively to help the body help itself." [Liss 1999]

  • Up until now, most currently available, both alternating current (AC waveform) and direct current (DC), cranial electrical stimulation (CES) devices have used relatively high stimulation voltages applied to the brain—typically 20-30 volts. Most of this delivered electrical energy is unnecessary to achieve strong therapeutic effects. Dr Liss knew this and orignally developed much lower voltage devices; he only added the higher voltages in order to convince people that they worked as they could then feel the stimulation.

  • From our independent biomedical engineering R&D, in parallel with the experiences from an ongoing, dedicated electromedicine clinical practice, we have developed on the Liss and other existing waveform cranial electrical stimulation (CES) technologies, to advance the field of CES and produce the world’s first Low Voltage transCranial (LVtC) Stimulator.

  • The LVtC Stimulator maintains or enhances the established therapeutic effects of CES, while very dramatically reducing overall user exposure to electrical energy.


LOW VOLTAGE TRANS-CRANIAL NEUROMODULATION

  • Enhancing Brain Neuromodulation. Gentle beneficial effects on levels of ‘neurotransmitters’ including Serotonin—related to mood, sexual function, appetite, sleep, memory, learning and some social behavior, and Melatonin—related to sleep-wake cycles, and on Cortisol and DHEA—adrenal stress and steroid hormones.

  • Brainwave Augmentation. Delivered stimulation frequencies are in the ‘Beta’ brainwave band of the normal waking state of consciousness of focused activity, decision-making and general alertness.

  • Central Pain Modulation. Beneficial effects on levels of ‘neurotransmitters’, Beta-Endorphin and GABA—related to transmission of pain signals and the body’s natural pain relief mechanisms.

  • Low Voltage Cranial Electrotherapy. Far lower (1000×) milli-volt range stimulation achieves comparative or greater therapeutic effects than high voltage devices (typically: 20-30 volts). Safer, wider application, less risks of side effects, no unnecessary optic nerve stimulation or dizziness. Easier and more comfortable application—no wet sponge pads, tingling or burning under pads; less chance of skin irritation.

  • Advanced Cranial Electrical Stimulation (CES). Technological development of the Liss Cranial Modulated Electric Energy Stimulator USA patents. Higher precision, more targeted, state of the art digital electronics generated and amplitude modulated stimulation waveform. Waveform is maintained even at real-world, higher electrical circuit resistances encountered when attached to the body. Far higher precision user-adjustable stimulation intensity.

  • For clinic or home use.

  • Robust high-end componentry construction. Including external casing and connectors. Each unit is a precision electronics instrument, assembled, and individually programmed and tested by our engineers in our Australian factory. 5 year warranty.

CONTACT US